Inhibrx Biosciences, Inc.
Ticker: 2007919
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY25
Revenue
2.00
+53.8%
Expenditure
33.74
+17.6%
Net Profit
-38.73
-35.2%
OPM %
-100.00%
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingINBX
20263Jun
Board Meeting
Election of Class II directors and ratification of the indep…
SEC Filing ↗